Cargando…
Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data
BACKGROUND: The efficacy and safety of secukinumab in patients with psoriasis has been established in randomised clinical trials. However, data on effectiveness and safety of secukinumab in Latin American real-world settings are scarce. OBJECTIVES: To evaluate the effectiveness and safety of secuki...
Autores principales: | Papp, Kim A., Gooderham, Melinda, Dei-Cas, Ignacio, LopezTello, Adriana, Garcia-Rodriguez, Juan C., Taveras, Carmen Yris, Rousselin, Azucena Hernández, Lavieri, Alberto, Maiolino, Mónica, Quintero, Delfina Guadalupe Villanueva, Rihakova, Lenka, Salibe, Mariano, Pertuz, Wilfran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823177/ https://www.ncbi.nlm.nih.gov/pubmed/36496547 http://dx.doi.org/10.1007/s13555-022-00849-0 |
Ejemplares similares
-
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry
por: Gooderham, Melinda, et al.
Publicado: (2022) -
35158 Adaptations in the PURE registry in response to the COVID 19 pandemic: The impact of well-designed modifications in real-world data collection in a psoriasis registry
por: Lynde, Charles, et al.
Publicado: (2022) -
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America
por: Papp, Kim A., et al.
Publicado: (2019) -
Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
por: Adsit, Sandra, et al.
Publicado: (2017) -
Dermatological manifestations and its association with SARS-CoV-2: a descriptive cross-sectional study from Guatemala()()
por: Hernández Rousselin, Azucena
Publicado: (2021)